Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
  1. 4 Open-market buy President & CEO bought 65,000 shares at $1.66 ($107,822)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 12,500 shares at $4.00 ($50,000)
  9. 4 Open-market buy 10% owner bought 250,000 shares at $4.00 ($1,000,000)
  10. 4 Open-market buy Chief Technology Officer bought 5,000 shares at $4.00 ($20,000)
  11. 4 Open-market buy Chief Retail Officer bought 5,000 shares at $4.00 ($20,000)
  12. 4 Open-market buy VP of Finance bought 5,000 shares at $4.00 ($20,000)
  13. 4 Open-market buy Exec Chairman of the Board bought 12,500 shares at $4.00 ($50,000)
  14. 4 Open-market buy President & CFO bought 12,500 shares at $4.00 ($50,000)
  15. 4 Open-market buy Chief Clinical & Reg Officer bought 2,500 shares at $4.00 ($10,000)
  16. 4 Open-market buy Director bought 6,250 shares at $4.00 ($25,000)
  17. 4 Open-market buy Director bought 7,500 shares at $4.00 ($30,000)
  18. 4 Open-market buy 10% owner bought 25,000 shares at $4.00 ($100,000)
  19. 4 Grant or award Director acquired 78,125 shares (grant or award)
  20. 4 Grant or award Director acquired 78,125 shares (grant or award)

Page 5 of 13 · 243 filings